During the past decade, Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 5 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte" #1 sponsor was "Charite University, Berlin, Germany" with 19 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "M. Schaefer, MD" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte" #1 collaborator was "Robert-Enke-Stiftung" with 2 trials as a collaborator, "Stanley Medical Research Institute" with 2 trials as a collaborator, "miha bodytec GmbH" with 2 trials as a collaborator, "Friede Springer Stiftung, Germany" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte" are "Alzheimer's Disease" (4 trials), "Mental Disorder" (4 trials), "Physical Activity" (4 trials), "Alzheimer Disease" (2 trials) and "Depression" (2 trials). Many other conditions were trialed in "Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte" in a lesser frequency.

Most popular intervention types in "Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte" are "Drug" (14 trials), "Diagnostic Test" (6 trials), "Other" (5 trials), "Behavioral" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Online questionnaire" (4 trials), "Memantine" (2 trials), "RO7234292 (RG6042)" (2 trials) and "high-intensive aerobe exercise" (2 trials). Other intervention names were less common.

The vast majority of trials in "Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherapy - Charité Campus Mitte, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".